Project Grant R21CA294233
Award Date
9/2/24
Completion Date
8/31/26
Dollars Obligated
$456K
Federal Agency
National Cancer Institute
Federal Grant Program
93.396
Assistance Type
Project Grant
Place of Performance
Plandome, NY 11030, USA
Similar Awards
This Project Grant award of $461,320.00 from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) supports research on risk factors and consequences of endometriosis among Black women. The key objectives are to: 1) Determine if established endometriosis risk factors in predominantly white populations, such as parity, age at menarche, and body size, are associated with endometriosis risk in...
This $547,047 federal Project Grant awarded by the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) will fund a research study at Georgetown University to test an innovative, multilevel intervention to improve cancer screening and genetic testing rates among non-Hispanic Black and Hispanic women. The study will bundle multicancer (breast and colorectal) screening navigation services with genetic risk assessment and counseling referrals. The primary goal is to...
This federal Project Grant award from the National Cancer Institute's Cancer Research Manpower program (CFDA 93.398) provides $132,825 to the Sloan-Kettering Institute for Cancer Research to develop and externally validate prognostic models for predicting survival in Black women with endometrial cancer following hysterectomy. The project aims to create clinical decision-making tools inclusive of minority populations to reduce cancer health disparities. Specific goals include: 1) building and...
This $505,613 Project Grant award from the National Cancer Institute (NCI) under the Cancer Detection and Diagnosis Research program (CFDA 93.394) supports the development of statistical and computational approaches to leverage genomic data for precision cancer prevention and risk stratification. The key objectives are to: (1) create deep learning-based methods that combine unsupervised and supervised techniques to identify tumor subtypes linked to poor outcomes, while integrating external...
This $2,163,115 Project Grant award, funded by the National Institute of Child Health and Human Development (CFDA 93.865 - Child Health and Human Development Extramural Research), aims to characterize the epigenomic landscape and genetic drivers of endometriosis severity. The primary research objectives include: Performing large-scale single-cell epigenomic profiling to understand disrupted gene regulation in low and high-stage endometriosis. Dissecting allele-specific mechanisms of gene...
This Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) provides $415,257 to the University of Virginia to conduct research aimed at identifying epigenetic and transcriptomic drivers of racial disparities in colorectal cancer risk and site-specific tumor development. The key products and services to be delivered under this 2-year award include: Identifying site-specific DNA methylation-associated gene expression signatures across different...
This $432,304 federal Project Grant award from the National Cancer Institute (NCI), under the Cancer Cause and Prevention Research program (CFDA 93.393), supports a research project titled "Enhanced Cancer Risk Predictions in Underrepresented Populations through Robust Multi-Source Data Integration." The project aims to develop novel data integration methods to enhance cancer risk prediction models, particularly for Black and Hispanic populations who face disproportionate cancer...
The National Cancer Institute (NCI) awarded a $455,111 Project Grant under CFDA 93.393 "Cancer Cause and Prevention Research" to the Sloan-Kettering Institute for Cancer Research in New York. The 2-year grant, awarded on September 5, 2023, will support research to "Leverage the Hidden Genome to Recover the Missing Heritability of Cancer." The project aims to 1) estimate additional heritability that can be explained by the "hidden genome" (regions of unknown...
This $334,233 federal Project Grant awarded by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program supports a research project conducted by the University of South Carolina to examine disparities in cancer care and outcomes. The project aims to: Describe and compare patterns of novel targeted therapies for lung and colon cancer by race, socioeconomic status, and urban/rural designation, and their impact on survival disparities. Describe and...
This $132,015 federal Project Grant award, provided by the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research), will support efforts by The Ohio State University to improve enrollment in clinical trials for gynecologic cancer patients, especially underrepresented populations. The grant will fund the development of a comprehensive molecular matching system to simplify identification of patients for specialized, targeted trials. It will also support collaborative initiatives with...